你目前无法使用部分二次筛选功能
请联系客服开通更多权限和功能！
| 申请号 | 申请类型 | 商品名 | 活性成分 | 中文活性成分 | 剂型/给药途径 | 批准日期 | 申请机构 |
|---|---|---|---|---|---|---|---|
| 761449 | BLA | TYENNE | TOCILIZUMAB-AAZG | INJECTABLE;INTRAVENOUS | 2025-03-14 | FRESENIUS KABI USA | |
| 761430 | BLA | IMAAVY | NIPOCALIMAB-AAHU | INJECTABLE;INJECTION | 2025-04-29 | JANSSEN BIOTECH | |
| 761429 | BLA | OPDIVO QVANTIG | NIVOLUMAB;HYALURONIDASE-NVHY | 玻璃酸酶;纳武利尤单抗 | INJECTABLE;INJECTION | 2024-12-27 | BRISTOL-MYERS SQUIBB |
| 761425 | BLA | PYZCHIVA | USTEKINUMAB-TTWE | INJECTABLE;SUBCUTANEOUS | SAMSUNG BIOEPIS CO LTD | ||
| 761420 | BLA | AVTOZMA | TOCILIZUMAB-ANOH | INJECTABLE;INTRAVENOUS | 2025-01-24 | CELLTRION INC | |
| 761417 | BLA | TEVIMBRA | TISLELIZUMAB-JSGR | INJECTABLE;INTRAVENOUS | 2024-12-26 | BEIGENE | |
| 761416 | BLA | ZIIHERA | ZANIDATAMAB-HRII | 泽尼达妥单抗 | INJECTABLE;INJECTION | 2024-11-20 | JAZZ PHARMS |
| 761411 | BLA | NIKTIMVO | axatilimab-csfr | INJECTABLE;INTRAVENOUS | 2024-08-14 | INCYTE CORP | |
| 761406 | BLA | YESINTEK | USTEKINUMAB-KFCE | INJECTABLE;INJECTION | 2024-11-29 | BIOCON BIOLOGICS INC | |
| 761404 | BLA | STOBOCLO | DENOSUMAB-BMWO | INJECTABLE;INJECTION | 2025-02-28 | CELLTRION INC | |
| 761399 | BLA | OMLYCLO | OMALIZUMAB-IGEC | INJECTABLE;INJECTION | 2025-03-07 | CELLTRION INC | |
| 761398 | BLA | BOMYNTRA | DENOSUMAB-BNHT | INJECTION | 2025-03-25 | FRESENIUS KABI USA LLC | |
| 761394 | BLA | DATROWAY | DATOPOTAMAB DERUXTECAN-DLNK | INJECTABLE; IV (INFUSION) | 2025-01-17 | DAIICHI SANKYO INC | |
| 761392 | BLA | OSPOMYV | DENOSUMAB-DSSB | INJECTABLE;SUBCUTANEOUS | 2025-02-13 | SAMSUNG BIOEPIS CO LTD | |
| 761391 | BLA | NEMLUVIO | NEMOLIZUMAB-ILTO | INJECTABLE;INJECTION | 2024-12-13 | GALDERMA LABS LP | |
| 761390 | BLA | NEMLUVIO | NEMOLIZUMAB-ILTO | INJECTABLE;INJECTION | GALDERMA LABS LP | ||
| 761388 | BLA | PIASKY | CROVALIMAB-AKKZ | INJECTABLE;INTRAVENOUS | 2024-06-20 | GENENTECH INC | |
| 761382 | BLA | ENZEEVU | AFLIBERCEPT-ABZV | INJECTABLE;INJECTION | 2024-08-09 | SANDOZ INC | |
| 761381 | BLA | OPDIVO QVANTIG | NIVOLUMAB;HYALURONIDASE-NVHY | 玻璃酸酶;纳武利尤单抗 | INJECTABLE;SUBCUTANEOUS | 2024-12-27 | BRISTOL-MYERS SQUIBB |
| 761380 | BLA | TEVIMBRA | islelizumab-jsgr | INJECTABLE;INJECTION | 2025-03-03 | BEIGENE |
